Media Releases

Sep 10 -  Immunovaccine Announces the Filing of its Final Short Form Prospectus
Sep 9 -  Immunovaccine to Present at the Rodman & Renshaw 12th Annual Healthcare Conference
Sep 3 -  Immunovaccine Prices Prospectus Offering
Aug 27 -  Immunovaccine Announces 2010 Second Quarter Results
Aug 11 -  Immunovaccine Announces Equity Offering
Jul 29 -  Immunovaccine Appoints Albert Scardino as New Board Member
Jul 12 -  Immunovaccine Licenses Clinical Stage Cancer Vaccine from Merck KGaA
Jun 29 -  Immunovaccine Signs Agreement with Oncothyreon to Develop Cancer Vaccine
Jun 11 -  Warwick Kimmins Science Scholarship Awarded
Jun 9 -  Immunovaccine Appoints Acting CFO
Jun 7 -  Immunovaccine Announces the Departure of its Chief Financial Officer
Jun 7 -  Immunovaccine Signs Agreement with Vaxil BioTherapeutics to Advance Potential Cancer Vaccine
May 17 -  Immunovaccine Appoints Paul Kirkconnell to Board, Announces Retirement of Denis Ryan
May 12 -  Immunovaccine Announces 2010 First Quarter Results
Apr 22 -  Immunovaccine Signs Research Agreement with Dana-Farber Cancer Institute
Apr 19 -  Immunovaccine Announces 2009 Year End Results
Apr 5 -  Immunovaccine Announces the Publication of DPX-0907 Preclinical Study
Mar 29 -  Immunovaccine Begins Patient Recruitment for Phase I Trial of DPX-0907 Cancer Vaccine
Mar 2 -  Immunovaccine Signs Licensing Deal with Pfizer Animal Health to Develop a Third Livestock Vaccine
Feb 23 -  Immunovaccine Appoints James Hall as New Board Member
Feb 8 -  Immunovaccine Presents Results for an Enhanced Anthrax Vaccine Candidate
Feb 4 -  Immunovaccine Provides Corporate Update
Feb 2 -  Immunovaccine Hires Investor Relations Firm
Jan 28 -  Immunovaccine Grants Stock Options